Fremanezumab Effectiveness and Tolerability in Clinical Routine: Interim Real-World-Data of the Observational FINESSE Study

被引：0
|
作者：
Straube, Andreas [1 ]
Broessner, Gregor [2 ]
Gaul, Charly [3 ]
Hamann, Xenia [4 ]
Kraya, Torsten [5 ,6 ]
Neeb, Lars [7 ,8 ]
机构：
[1] Ludwig Maximilians Univ Munchen, Dept Neurol, Univ Hosp, Munich, Germany
[2] Innsbruck Med Univ, Dept Neurol, Innsbruck, Austria
[3] Headache Ctr Frankfurt, Frankfurt, Germany
[4] Teva GmbH, Ulm, Germany
[5] Hosp Sankt Georg Leipzig gGmbH, Dept Neurol, Leipzig, Germany
[6] Univ Hosp, Headache Ctr Halle, Dept Neurol, Halle, Germany
[7] Helios Global Hlth, Berlin, Germany
[8] Charite Univ Med Berlin, Dept Neurol, Berlin, Germany
来源：
CEPHALALGIA | 2023年 / 43卷 / 1supp期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
IHC23-PO-2
引用
收藏
页码：243 / 244
页数：2
相关论文
共 50 条
  • [1] Fremanezumab effectiveness and tolerability in clinical routine: interim real-world-data of the observational FINESSE study
    Straube, A.
    Broessner, G.
    Gaul, C.
    Hamann, X.
    Kraya, T.
    Neeb, L.
    [J]. JOURNAL OF HEADACHE AND PAIN, 2024, 25
  • [2] OBSERVATIONAL MULTICENTER STUDY ON EFFECTIVENESS AND TOLERABILITY OF ALIROCUMAB IN REAL WORLD, THE OMERO STUDY: INTERIM DATA FROM THE FIST 352 PARTICIPANTS
    Pisciotta, L.
    Catapano, A. L.
    Maggioni, A. P.
    Rossi, F.
    Tirone, G.
    Notarianni, L.
    Agnelli, G.
    [J]. ATHEROSCLEROSIS, 2021, 331 : E166 - E166
  • [3] Observational multicentre study on effectiveness and tolerability of Alirocumab in real world, the OMERO study: interim data from the first 699 patients
    Catapano, Alberico Luigi
    Maggioni, Aldo Pietro
    Rossi, Francesco
    Tirone, Giampaolo
    Notarianni, Lucia
    Agnelli, Giancarlo
    Cesaro, Arturo
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0G) : G193 - +
  • [4] Observational multicentre study on effectiveness and tolerability of Alirocumab in real world, the OMERO study: interim data from the first 699 patients
    Catapano, Alberico Luigi
    Maggioni, Aldo Pietro
    Rossi, Francesco
    Tirone, Giampaolo
    Notarianni, Lucia
    Agnelli, Giancarlo
    Cesaro, Arturo
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL G)
  • [5] Response to fremanezumab for preventive treatment in migraine in routine clinical practice: First data from the FINESSE study
    Straube, A.
    Broessner, G.
    Gaul, C.
    Hamann, X.
    Kraya, T.
    Schaurete, I
    Carr, K.
    Neeb, L.
    [J]. HEADACHE, 2022, 62 : 160 - 161
  • [6] Interim Analysis on the Effectiveness of Fremanezumab for the Preventive Treatment of Migraine: The Observational PEARL Study
    Ashina, M.
    Mitsikostas, D.
    Amin, F. M.
    Kokturk, P.
    Sahin, G.
    Schankin, C.
    Dorman, P.
    Pozo-Rosich, P.
    Lyras, L.
    Myers, C.
    Ahn, A.
    Tassorelli, C.
    [J]. JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1):
  • [7] Real-world effectiveness of fremanezumab for the preventive treatment of migraine: Interim analysis of the pan-European, prospective, observational, phase 4 PEARL study
    Ashina, Messoud
    Mitsikostas, Dimos D.
    Amin, Faisal Mohammad
    Kokturk, Pinar
    Schankin, Christoph J.
    Sahin, Gurdal
    Pozo-Rosich, Patricia
    Dorman, Paul J.
    Nezadal, Tomas
    Poole, Anne Christine
    Martins, Isabel Pavao
    Sumelahti, Marja-Liisa
    Campos, Verena Ramirez
    Ahn, Andrew H.
    Lyras, Leonidas
    Tassorelli, Cristina
    [J]. CEPHALALGIA, 2023, 43 (11)
  • [8] Effectiveness of Fremanezumab for the Preventive Treatment of Migraine: Second Interim Analysis of the Observational PEARL Study
    Ashina, Messoud
    Mitsikostas, Dimos D.
    Amin, Faisal M.
    Kokturk, Pinar
    Sahin, Gurdal
    Schankin, Christoph J.
    Dorman, Paul J.
    Pozo-Rosich, Patricia
    Lyras, Leonidas
    Myers, Coleen
    Ahn, Andrew
    Tassorelli, Cristina
    [J]. CEPHALALGIA, 2022, 42 (1_SUPPL) : 93 - 94
  • [9] Effectiveness of Fremanezumab for the Preventive Treatment of Migraine: Second Interim Analysis of the Observational PEARL Study
    Ashina, Messoud
    Mitsikostas, Dimos D.
    Amin, Faisal M.
    Kokturk, Pinar
    Sahin, Gurdal
    Schankin, Christoph J.
    Dorman, Paul J.
    Pozo-Rosich, Patricia
    Lyras, Leonidas
    Myers, Coleen
    Ahn, Andrew H.
    Tassorelli, Cristina
    [J]. NEUROLOGY, 2023, 100 (17)
  • [10] Comparing the effectiveness and tolerability of Perampanel and Brivaracetam: a preliminary retrospective, observational study based on real-world data
    Liguori, C.
    Manfredi, N.
    Renna, R.
    Izzi, F.
    Pagliuca, M.
    Pagliuca, F.
    Mercuri, N. B.
    Placidi, F.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 290 - 290
12345